11 - 20 out of 278Page size: 10
  1. 2022

  2. Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

    van Rijswijck, D. M. H., Bondt, A., Hoek, M., van der Straten, K., Caniels, T. G., Poniman, M., Eggink, D., Reusken, C., de Bree, G. J., Sanders, R. W., van Gils, M. J. & Heck, A. J. R., 1 Dec 2022, In: Nature communications. 13, 1, 6103.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers

    del Moral-Sánchez, I., Russell, R. A., Schermer, E. E., Cottrell, C. A., Allen, J. D., Torrents de la Peña, A., LaBranche, C. C., Kumar, S., Crispin, M., Ward, A. B., Montefiori, D. C., Sattentau, Q. J., Sliepen, K. & Sanders, R. W., 1 Dec 2022, In: npj Vaccines. 7, 1, 27.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein

    van Schooten, J., Farokhi, E., Schorcht, A., van den Kerkhof, T. L. G. M., Gao, H., van der Woude, P., Burger, J. A., Meesters, T. G. R., Bijl, T., Ghalaiyini, R., Turner, H. L., Dorning, J., van Schaik, B. D. C., van Kampen, A. H. C., Labranche, C. C., Stanfield, R. L., Sok, D., Montefiori, D. C., Burton, D. R., Seaman, M. S., & 5 othersOzorowski, G., Wilson, I. A., Sanders, R. W., Ward, A. B. & van Gils, M. J., 1 Dec 2022, In: Nature communications. 13, 1, 4515.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

    Sliepen, K., Radić, L., Capella-Pujol, J., Watanabe, Y., Zon, I., Chumbe, A., Lee, W-H., de Gast, M., Koopsen, J., Koekkoek, S., del Moral-Sánchez, I., Brouwer, P. J. M., Ravichandran, R., Ozorowski, G., King, N. P., Ward, A. B., van Gils, M. J., Crispin, M., Schinkel, J. & Sanders, R. W., 1 Dec 2022, In: Nature communications. 13, 1, 7271.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

    Gallinaro, A., Pirillo, M. F., Aldon, Y., Cecchetti, S., Michelini, Z., Tinari, A., Borghi, M., Canitano, A., McKay, P. F., Bona, R., Vescio, M. F., Grasso, F., Blasi, M., Baroncelli, S., Scarlatti, G., LaBranche, C., Montefiori, D., Klotman, M. E., Sanders, R. W., Shattock, R. J., & 2 othersNegri, D. & Cara, A., 1 Dec 2022, In: npj Vaccines. 7, 1, 44.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates

    Reiss, E. I. M. M., van Haaren, M. M., van Schooten, J., Claireaux, M. A. F., Maisonnasse, P., Antanasijevic, A., Allen, J. D., Bontjer, I., Torres, J. L., Lee, W-H., Ozorowski, G., Vázquez Bernat, N., Kaduk, M., Aldon, Y., Burger, J. A., Chawla, H., Aartse, A., Tolazzi, M., Gao, H., Mundsperger, P., & 10 othersCrispin, M., Montefiori, D. C., Karlsson Hedestam, G. B., Scarlatti, G., Ward, A. B., Le Grand, R., Shattock, R., Dereuddre-Bosquet, N., Sanders, R. W. & van Gils, M. J., Dec 2022, In: npj Vaccines. 7, 1, p. 152 152.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 22 Nov 2022, In: Frontiers in immunology. 13, 1091668.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  9. Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer

    van Schooten, J., Schorcht, A., Farokhi, E., Umotoy, J. C., Gao, H., van den Kerkhof, T. L. G. M., Dorning, J., Rijkhold Meesters, T. G., van der Woude, P., Burger, J. A., Bijl, T., Ghalaiyini, R., de la Peña, A. T., Turner, H. L., Labranche, C. C., Stanfield, R. L., Sok, D., Schuitemaker, H., Montefiori, D. C., Burton, D. R., & 6 othersOzorowski, G., Seaman, M. S., Wilson, I. A., Sanders, R. W., Ward, A. B. & van Gils, M. J., Nov 2022, In: PLoS pathogens. 18, 11, e1010945.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection

    Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., van Rijswijk, J., de Jong, M. D., de Bree, G. J., Peters, E. J. G., Smulders, Y. M., Sanders, R. W., van Gils, M. J., van der Hoek, L. & Bomers, M. K., 21 Oct 2022, In: iScience. 25, 10, 105105.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Structure of the hepatitis C virus E1E2 glycoprotein complex

    Torrents de la Peña, A., Sliepen, K., Eshun-Wilson, L., Newby, M. L., Allen, J. D., Zon, I., Koekkoek, S., Chumbe, A., Crispin, M., Schinkel, J., Lander, G. C., Sanders, R. W. & Ward, A. B., 21 Oct 2022, In: Science. 378, 6617, p. 263-269 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 ...28 Next

ID: 82305